DK1135128T3 - Nye behandlingsfremgangsmåder - Google Patents

Nye behandlingsfremgangsmåder

Info

Publication number
DK1135128T3
DK1135128T3 DK99960293T DK99960293T DK1135128T3 DK 1135128 T3 DK1135128 T3 DK 1135128T3 DK 99960293 T DK99960293 T DK 99960293T DK 99960293 T DK99960293 T DK 99960293T DK 1135128 T3 DK1135128 T3 DK 1135128T3
Authority
DK
Denmark
Prior art keywords
treatment methods
new treatment
new
methods
treatment
Prior art date
Application number
DK99960293T
Other languages
Danish (da)
English (en)
Inventor
Lisa Benincosa
William Jusko
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1135128(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1135128T3 publication Critical patent/DK1135128T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK99960293T 1998-11-12 1999-11-12 Nye behandlingsfremgangsmåder DK1135128T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824893.3A GB9824893D0 (en) 1998-11-12 1998-11-12 Novel method of treatment
PCT/US1999/026746 WO2000027341A2 (en) 1998-11-12 1999-11-12 Novel method of treatment

Publications (1)

Publication Number Publication Date
DK1135128T3 true DK1135128T3 (da) 2007-11-05

Family

ID=10842389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99960293T DK1135128T3 (da) 1998-11-12 1999-11-12 Nye behandlingsfremgangsmåder

Country Status (40)

Country Link
EP (2) EP1759698A1 (xx)
JP (1) JP2003521455A (xx)
KR (2) KR20010080440A (xx)
CN (3) CN1771943A (xx)
AP (2) AP2005003432A0 (xx)
AR (2) AR029149A1 (xx)
AT (1) ATE366573T1 (xx)
AU (1) AU768303B2 (xx)
BG (2) BG65577B1 (xx)
BR (1) BR9915284A (xx)
CA (1) CA2350425C (xx)
CO (1) CO5150158A1 (xx)
CY (1) CY1106892T1 (xx)
CZ (1) CZ299801B6 (xx)
DE (1) DE69936533T2 (xx)
DK (1) DK1135128T3 (xx)
DZ (1) DZ2938A1 (xx)
EA (2) EA200700968A1 (xx)
ES (1) ES2289833T3 (xx)
GB (1) GB9824893D0 (xx)
HK (1) HK1041202B (xx)
HR (1) HRP20010344B1 (xx)
HU (1) HUP0104262A3 (xx)
IL (1) IL143088A0 (xx)
MA (1) MA26759A1 (xx)
MY (1) MY128347A (xx)
NO (1) NO328391B1 (xx)
NZ (1) NZ527132A (xx)
OA (1) OA12193A (xx)
PE (1) PE20001239A1 (xx)
PL (1) PL349421A1 (xx)
PT (1) PT1135128E (xx)
RS (1) RS50130B (xx)
SK (1) SK286357B6 (xx)
TR (1) TR200101348T2 (xx)
TW (1) TWI234456B (xx)
UA (1) UA79730C2 (xx)
UY (2) UY25797A1 (xx)
WO (1) WO2000027341A2 (xx)
ZA (1) ZA200103793B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030920A1 (es) 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
US20050107450A1 (en) * 2001-12-21 2005-05-19 Brown Kathleen K. Dosing regimen for ppar-gamma activators
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH0469331A (ja) * 1990-07-10 1992-03-04 Asahi Chem Ind Co Ltd 徐放性エマルジョン製剤
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
US5478853A (en) * 1992-10-12 1995-12-26 Adir Et Compagnie Thazolidinedione compounds
CA2115587A1 (en) * 1993-02-18 1994-08-19 Hayato Kihara Styrene copolymers, polystyrene compositions, processes for producing styrene copolymers, and injection-molded articles
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
EP0719140B1 (en) * 1993-09-15 2007-10-31 Daiichi Sankyo Company, Limited Use of thiazolidinediones to prevent or delay onset of niddm
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes

Also Published As

Publication number Publication date
NO328391B1 (no) 2010-02-08
DE69936533D1 (de) 2007-08-23
CN1771943A (zh) 2006-05-17
AU768303B2 (en) 2003-12-04
BG110061A (bg) 2008-12-30
NO20012301D0 (no) 2001-05-10
EP1135128A4 (en) 2003-07-16
HK1041202B (zh) 2007-10-05
HUP0104262A3 (en) 2003-06-30
BR9915284A (pt) 2002-02-13
PL349421A1 (en) 2002-07-29
HUP0104262A2 (en) 2002-08-28
AR029317A1 (es) 2003-06-25
MY128347A (en) 2007-01-31
ES2289833T3 (es) 2008-02-01
JP2003521455A (ja) 2003-07-15
UY25801A1 (es) 2000-08-21
GB9824893D0 (en) 1999-01-06
MA26759A1 (fr) 2004-12-20
CZ299801B6 (cs) 2008-11-26
WO2000027341A3 (en) 2000-09-08
PE20001239A1 (es) 2000-12-24
EP1135128B1 (en) 2007-07-11
CN101244062A (zh) 2008-08-20
CY1106892T1 (el) 2012-01-25
EA009192B1 (ru) 2007-12-28
CA2350425C (en) 2009-06-02
UA79730C2 (en) 2007-07-25
CN1354661A (zh) 2002-06-19
AU1719600A (en) 2000-05-29
TR200101348T2 (tr) 2002-02-21
CZ20011656A3 (cs) 2002-06-12
EA200100539A1 (ru) 2001-12-24
HRP20010344B1 (en) 2008-02-29
HRP20010344A2 (en) 2002-06-30
YU37401A (sh) 2005-07-19
CN1235586C (zh) 2006-01-11
AP1580A (en) 2006-02-24
OA12193A (en) 2006-05-09
AP2005003432A0 (en) 2005-12-31
PT1135128E (pt) 2007-10-12
BG65577B1 (bg) 2009-01-30
KR20070048279A (ko) 2007-05-08
HK1041202A1 (en) 2002-07-05
TWI234456B (en) 2005-06-21
EP1135128A2 (en) 2001-09-26
WO2000027341A2 (en) 2000-05-18
NZ527132A (en) 2005-01-28
UY25797A1 (es) 2000-12-29
DZ2938A1 (fr) 2004-03-15
SK286357B6 (sk) 2008-08-05
KR20010080440A (ko) 2001-08-22
AR029149A1 (es) 2003-06-18
SK6422001A3 (en) 2001-12-03
EP1759698A1 (en) 2007-03-07
RS50130B (sr) 2009-03-25
BG105569A (en) 2002-01-31
NO20012301L (no) 2001-07-09
EA200700968A1 (ru) 2008-06-30
CO5150158A1 (es) 2002-04-29
ATE366573T1 (de) 2007-08-15
ZA200103793B (en) 2002-06-05
CA2350425A1 (en) 2000-05-18
DE69936533T2 (de) 2008-03-13
IL143088A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
NO20014960L (no) Nye fremgangsmåter for behandling
FI20000863A (fi) Uusi hoitomenetelmä
DE69828821D1 (de) Wasserbehandlungsverfahren
DE60028849D1 (de) Sterilisationsmethode
NO20014950L (no) Nye behandlingsmetoder
ID30025A (id) Metode perlakuan tekstil
ID27841A (id) Turunan-turunan biaril terapeutik
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20020810L (no) Nye fenylpiperaziner
NO20010916D0 (no) Nye antibakterielle isoksazolinoner
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20005179D0 (no) Medikament behandling
NO20010860D0 (no) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
DE69908232D1 (de) Laserbehandlungsvorrichtung
DE69907803D1 (de) Laserbehandlungsgerät
NO20013337D0 (no) Ny behandling
NO20005857L (no) Nye blandinger
NO20010584L (no) Nye forbindelser
DK1135128T3 (da) Nye behandlingsfremgangsmåder
NO20003844D0 (no) Prosessanordning
NO20011262L (no) Nye forbindelser
NO991097D0 (no) Nye fremgangsmÕter
DE69912763D1 (de) Behandlungsanlage
NO983505D0 (no) Nye fenantrider